Literature DB >> 25061711

Medial temporal lobe atrophy in Alzheimer's disease/mild cognitive impairment with depression.

V Dhikav1, M Sethi, K S Anand.   

Abstract

OBJECTIVE: Depression is common in patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI). Patients with depression have an earlier onset and rapid progression of cognitive decline. Medial temporal lobe atrophy (MTA) is common in AD and MCI, and some degree of atrophy is found in almost all patients. In the present study, an attempt was made to know if MTA is more common in patients with AD/MCI with depression than those without it.
METHODS: Patients reporting to the outpatient department of a neurology centre of a tertiary care hospital were recruited for the present study. After initial general physical and neurological examination, they were evaluated using National Institute of Neurological and Communicative Disorders and Stroke and Related Disorders Association criteria for diagnosis of AD. Clinical Dementia rating scale was used for the diagnosis of MCI. Cornell scale for depression in dementia (CSDD) was used.
RESULTS: We found 20 cases with depression as per CSDD out of a sample of 37 patients (male:female = 30:7). There were 26 patients with AD and 11 with MCI. The mean age of all patients was 72.33 ± 6.45 years. The mean mini mental status examination score was 19.00 ± 6.73. The mean time since diagnosis was 4.19 ± 3.26 years. The mean Scheltens visual rating scale score for right MTA was 2.08 ± 0.95 and was 2.05 ± 0.94 for the left. Both scores did not differ statistically when analyzed using paired t-test (p > 0.05). However, difference in those with depression (2.36 ± 0.95) from those without depression (1.60 ± 0.74) was significant (p < 0.05).
CONCLUSION: MTA scores were higher in those with AD/MCI with depression than those without it.

Entities:  

Mesh:

Year:  2014        PMID: 25061711      PMCID: PMC4148828          DOI: 10.1259/bjr.20140150

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  21 in total

Review 1.  Potential predictors of hippocampal atrophy in Alzheimer's disease.

Authors:  Vikas Dhikav; Kuljeet Anand
Journal:  Drugs Aging       Date:  2011-01-01       Impact factor: 3.923

Review 2.  Depression and the risk for dementia.

Authors:  Lars Vedel Kessing
Journal:  Curr Opin Psychiatry       Date:  2012-11       Impact factor: 4.741

3.  Depression in dementia: epidemiology, mechanisms, and treatment.

Authors:  Daniela Enache; Bengt Winblad; Dag Aarsland
Journal:  Curr Opin Psychiatry       Date:  2011-11       Impact factor: 4.741

4.  Do continued antidepressants protect against dementia in patients with severe depressive disorder?

Authors:  Lars Vedel Kessing; Julie Lyng Forman; Per Kragh Andersen
Journal:  Int Clin Psychopharmacol       Date:  2011-11       Impact factor: 1.659

5.  Glucocorticoids may initiate Alzheimer's disease: a potential therapeutic role for mifepristone (RU-486).

Authors:  Vikas Dhikav; Kuljeet Singh Anand
Journal:  Med Hypotheses       Date:  2006-11-14       Impact factor: 1.538

6.  Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.

Authors:  Esther S C Korf; Lars-Olof Wahlund; Pieter Jelle Visser; Philip Scheltens
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

7.  Hippocampal volume change in depression: late- and early-onset illness compared.

Authors:  Adrian J Lloyd; I Nicol Ferrier; Robert Barber; Anil Gholkar; Allan H Young; John T O'Brien
Journal:  Br J Psychiatry       Date:  2004-06       Impact factor: 9.319

8.  Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

Authors:  P Scheltens; D Leys; F Barkhof; D Huglo; H C Weinstein; P Vermersch; M Kuiper; M Steinling; E C Wolters; J Valk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

9.  Hippocampal atrophy in recurrent major depression.

Authors:  Y I Sheline; P W Wang; M H Gado; J G Csernansky; M W Vannier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

10.  The complex relationship between depression and dementia.

Authors:  Krishna Prasad Muliyala; Mathew Varghese
Journal:  Ann Indian Acad Neurol       Date:  2010-12       Impact factor: 1.383

View more
  12 in total

1.  Clinicopathological correlates of depression in early Alzheimer's disease in the NACC.

Authors:  Sarah T McCutcheon; Dingfen Han; Juan Troncoso; Vassilis E Koliatsos; Marilyn Albert; Constantine G Lyketsos; Jeannie-Marie S Leoutsakos
Journal:  Int J Geriatr Psychiatry       Date:  2016-02-14       Impact factor: 3.485

2.  Brain Morphometric Correlates of Depressive Symptoms among Patients with and without Dementia.

Authors:  Maria Lage Barca; Dag Alnæs; Knut Engedal; Karin Persson; Rannveig Sakshaug Eldholm; Nikias Siafarikas; Ina Selseth Almdahl; Maria Stylianou-Korsnes; Ingvild Saltvedt; Geir Selbæk; Lars T Westlye
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2022-06-23

3.  Depressive Symptoms Have Distinct Relationships With Neuroimaging Biomarkers Across the Alzheimer's Clinical Continuum.

Authors:  Inès Moulinet; Edelweiss Touron; Florence Mézenge; Sophie Dautricourt; Vincent De La Sayette; Denis Vivien; Natalie L Marchant; Géraldine Poisnel; Gaël Chételat
Journal:  Front Aging Neurosci       Date:  2022-06-20       Impact factor: 5.702

4.  Functional Connectivity and Complexity in the Phenomenological Model of Mild Cognitive-Impaired Alzheimer's Disease.

Authors:  Surya Das; Subha D Puthankattil
Journal:  Front Comput Neurosci       Date:  2022-06-06       Impact factor: 3.387

5.  Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress.

Authors:  Mohammed Ragab Abdel-Aziz Ali; Amira Morad Hussein Abo-Youssef; Basim Anwar Shehata Messiha; Mahmoud Mohamed Khattab
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-30       Impact factor: 3.000

6.  Brain Shape Changes Associated With Cerebral Atrophy in Healthy Aging and Alzheimer's Disease.

Authors:  Yana Blinkouskaya; Johannes Weickenmeier
Journal:  Front Mech Eng       Date:  2021-07-19

Review 7.  Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

Authors:  Xin Du; Terence Y Pang
Journal:  Front Psychiatry       Date:  2015-03-09       Impact factor: 4.157

8.  Issues with normative data of hippocampal volumetry in Indian population.

Authors:  Kuljeet Singh Anand; Vikas Dhikav; Sharmila Doraswamy; Umesh Chandra Garga
Journal:  Ann Indian Acad Neurol       Date:  2015 Apr-Jun       Impact factor: 1.383

9.  Correlation between hippocampal volumes and medial temporal lobe atrophy in patients with Alzheimer's disease.

Authors:  Vikas Dhikav; Sharmila Duraiswamy; Kuljeet Singh Anand
Journal:  Ann Indian Acad Neurol       Date:  2017 Jan-Mar       Impact factor: 1.383

10.  Hippocampal volumes among older Indian adults: Comparison with Alzheimer's disease and mild cognitive impairment.

Authors:  Vikas Dhikav; Sharmila Duraisamy; Kuljeet Singh Anand; Umesh Chandra Garga
Journal:  Ann Indian Acad Neurol       Date:  2016 Apr-Jun       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.